K MITCHELL NAFICY: Open Payments
NPI 1699755264 · SAN JUAN CAPISTRANO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 46 payments from 11 companies in 2025. Trend: 2023 $276 · 2024 $476 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $239 |
| Indivior Inc. | 7 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $183 |
| Vanda Pharmaceuticals Inc. | 4 | $126 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Braeburn Inc. | 3 | $67 |
| Exact Sciences Corporation | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, REXULTI, FANAPT, BRIXADI, HETLIOZ, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
